V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10435685 | 10073077 | 1.56 | 55 | null | null | 2019-10-12 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | THALIDOMIDE | 101680680 |
| 10453660 | 10073078 | 1.64 | 85.4 | null | 2017-10-25 | 2017-12-12 | FEC | 02 | null | CARDAMON TRIAL | 101746091 |
| 10475499 | 10073082 | 1.56 | 62 | Curative (C) | null | 2019-11-22 | null | 02 | N | ABEMACICLIB + FULVESTRANT | 101779506 |
| 10330421 | 10073088 | 1.72 | 79.5 | Palliative (P) | 2021-11-16 | 2021-11-16 | Bortezomib + MELPHALAN | 02 | N | EVEROLIMUS | 100171223 |
| 10420624 | 10073167 | 1.74 | null | null | 2019-10-24 | 2020-11-30 | IBRUTINIB | 02 | null | IBRUTINIB | 100147510 |
| 10422524 | 10073169 | 1.64 | 59.5 | Adjuvant (A) | 2018-01-14 | 2019-08-27 | IBRUTINIB | 02 | N | IBRUTINIB | 101842696 |
| 10422565 | 10073170 | 1.88 | 69 | null | null | null | IBRUTINIB | 02 | null | IBRUTINIB | 101073467 |
| 10425225 | 10073171 | 1.7 | 58.4 | Palliative (P) | 2020-10-05 | 2020-11-02 | Rituximab | N | N | RITUXIMAB | 100327931 |
| 10425374 | 10073172 | 1.75 | 72.6 | Palliative (P) | 2021-11-13 | 2021-11-13 | IBRUTINIB | 02 | N | IBRUTINIB | 100032821 |
| 10428724 | 10073173 | 1.52 | 50 | Palliative (P) | 2021-10-30 | 2021-10-31 | IBRUTINIB | 02 | N | RITUXIMAB | 100854255 |
| 10448048 | 10073184 | 1.74 | 59 | null | 2021-09-07 | 2021-11-22 | Rituximab | 02 | null | RITUXIMAB | 100622606 |
| 10448730 | 10073185 | 1.8 | 92.2 | null | 2022-03-22 | 2022-05-09 | IBRUTINIB | 02 | null | IBRUTINIB | 100108570 |
| 10454051 | 10073189 | 1.68 | 92.5 | Palliative (P) | 2018-05-17 | 2021-04-15 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100901255 |
| 10454266 | 10073190 | 0 | 0 | Neo-adjuvant (N) | 2019-10-17 | 2019-10-23 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100238088 |
| 10456068 | 10073192 | 1.91 | 100.4 | null | 2021-05-27 | 2021-07-01 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101528237 |
| 10465186 | 10073202 | 1.75 | 39.8 | Palliative (P) | 2021-01-16 | 2021-06-06 | null | null | N | LENALIDOMIDE | 100606435 |
| 10465690 | 10073205 | 1.6 | 0 | null | 2021-04-02 | 2021-04-02 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100044453 |
| 10465966 | 10073207 | 1.68 | 62.05 | null | 2021-11-26 | 2021-12-24 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100011266 |
| 10466645 | 10073210 | 0 | 52.45 | Palliative (P) | 2021-07-17 | 2021-07-23 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100970607 |
| 10467595 | 10073213 | 1.66 | 0 | Palliative (P) | 2020-01-08 | 2022-03-13 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100016785 |
| 10470330 | 10073216 | 1.73 | 63.3 | null | null | 2022-01-21 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | null | LENALIDOMIDE | 100449604 |
| 10471114 | 10073217 | 1.6 | null | Palliative (P) | 2022-05-24 | 2022-05-26 | null | null | N | ENZALUTAMIDE | 100512146 |
| 10474775 | 10073224 | 1.78 | 86 | null | 2020-12-15 | 2020-12-15 | null | null | null | TRIAL UNSPECIFIED | 100544205 |
| 10474959 | 10073225 | 1.65 | 70.9 | null | null | 2020-04-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100133294 |
| 10475839 | 10073226 | null | 73.3 | 03 | null | 2021-01-07 | Capecitabine | 02 | N | CAPECITABINE | 101566247 |
| 10476208 | 10073229 | 0 | 106.4 | 03 | 2022-04-16 | 2022-05-21 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101219215 |
| 10476349 | 10073230 | 1.66 | 0 | null | 2020-05-02 | 2021-09-21 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100795698 |
| 10478223 | 10073232 | 1.79 | 66.2 | 02 | 2021-05-28 | 2021-05-28 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100055196 |
| 10479358 | 10073234 | 1.6 | 60 | Palliative (P) | 2019-06-21 | 2019-09-12 | Capecitabine | 02 | N | CAPECITABINE | 100276862 |
| 10479827 | 10073235 | 1.65 | null | null | 2022-04-16 | 2022-05-07 | Abiraterone | 02 | null | ABIRATERONE | 101459334 |
| 10480215 | 10073236 | 1.68 | 84 | 03 | 2020-08-28 | 2022-02-14 | null | null | null | TRIAL UNSPECIFIED | 100454175 |
| 10480995 | 10073237 | 1.66 | 77 | null | 2020-09-04 | 2021-07-11 | null | null | null | TRIAL UNSPECIFIED | 101534738 |
| 10051750 | 10073240 | 1.56 | 103 | null | 2020-12-25 | 2021-03-08 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100309116 |
| 10075178 | 10073242 | null | 57.7 | null | 2021-06-05 | 2021-06-05 | null | null | null | CAPECITABINE | 101049512 |
| 10146407 | 10073245 | 1.58 | 81 | Palliative (P) | 2020-09-20 | 2020-12-14 | PACLITAXEL | 02 | N | PACLITAXEL | 100737526 |
| 10161709 | 10073246 | 1.76 | 81 | null | 2021-08-25 | 2021-10-03 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100645879 |
| 10206060 | 10073249 | 1.62 | 90.2 | null | 2020-05-08 | 2020-05-18 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100933397 |
| 10214003 | 10073252 | 1.57 | 54.8 | Palliative (P) | 2021-06-14 | 2021-09-16 | Avelumab | 02 | N | DARATUMUMAB | 101153356 |
| 10240827 | 10073254 | 1.82 | 66.5 | null | 2022-05-14 | 2022-05-26 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101487122 |
| 10241543 | 10073255 | 1.77 | 74.2 | null | 2018-05-23 | 2021-01-17 | Avelumab | 02 | null | DARATUMUMAB | 100279137 |
| 10246813 | 10073259 | 1.75 | null | Palliative (P) | 2018-06-07 | 2018-06-24 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101236487 |
| 10249969 | 10073260 | 1.65 | 54.1 | null | 2019-09-24 | 2019-10-28 | Oxaliplatin + Modified de Gramont | 02 | null | FLUOROURACIL + OXALIPLATIN | 101310758 |
| 10255434 | 10073263 | 1.76 | 54.6 | null | null | 2019-01-28 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100560679 |
| 10255810 | 10073264 | 1.76 | 71.5 | Neo-adjuvant (N) | 2017-02-03 | 2017-12-21 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101728894 |
| 10256135 | 10073265 | 1.62 | null | Palliative (P) | 2019-05-24 | 2019-05-24 | Bendamustine+Rituximab(Sub Courses) | 02 | N | BENDAMUSTINE + RITUXIMAB | 100184230 |
| 10257928 | 10073266 | 1.77 | 118.7 | Palliative (P) | 2020-08-17 | 2020-08-24 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101705529 |
| 10260903 | 10073269 | 1.73 | 75.7 | null | 2016-01-03 | 2018-08-09 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101188771 |
| 10264301 | 10073270 | 1.65 | 95 | Palliative (P) | 2019-08-20 | 2019-11-28 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100908814 |
| 10264477 | 10073271 | 1.75 | 74.3 | null | 2017-02-22 | 2018-03-17 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100645930 |
| 10265879 | 10073272 | 1.65 | 50 | Palliative (P) | 2019-08-07 | 2019-11-16 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100648458 |